Related Experiment Video
Updated: Aug 9, 2026

Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice
Published on: March 24, 2017
TNF receptor deficiency reveals a translational control mechanism for adriamycin-induced Fas expression in cardiac
Yu-Chin Lien1, Chotiros Daosukho, Daret K St Clair
1Graduate Center for Toxicology, University of Kentucky, Lexington, KY 40536, USA.
Abstract:
Adriamycin, ADR, a potent chemotherapeutic agent, has been demonstrated to cause cardiomyocyte apoptosis, in part, via the Fas/Fas ligand-mediated cell death pathway. Our previous studies suggested that TNF-alpha receptors may mediate cardioprotection against ADR toxicity by the suppression of the Fas-mediated pathway. However, the role of TNF-alpha receptors in this process is unclear. In the present study, we extended our initial observation to determine the molecular mechanisms by which ADR induced Fas expression in the presence and absence of TNF receptors. Our results demonstrated that ADR-mediated p53 and AP-1 interaction and increased Fas mRNA levels independent of TNF receptors. However, the levels of Fas proteins only increased in the cardiac tissues of TNF receptor-deficient mice. These results demonstrated that the suppression of ADR-induced Fas expression by TNF receptors was not regulated at transcriptional levels, but may be regulated at a translational level.
Insights
Adriamycin (ADR) causes heart cell death. Tumor necrosis factor (TNF) receptors protect against ADR toxicity by regulating Fas expression at the protein level, not the mRNA level.
Area of Science:
- Cardiovascular research
- Molecular biology
- Cancer therapeutics
Background:
- Adriamycin (ADR) induces cardiomyocyte apoptosis through the Fas/Fas ligand pathway.
- Tumor necrosis factor-alpha (TNF-alpha) receptors may offer cardioprotection against ADR toxicity by suppressing Fas-mediated cell death.
- The precise role of TNF-alpha receptors in modulating ADR-induced Fas expression remains unclear.
Purpose of the Study:
- To elucidate the molecular mechanisms by which ADR induces Fas expression.
- To investigate the role of TNF-alpha receptors in this process, particularly at transcriptional and translational levels.
Main Methods:
- Examining ADR-induced Fas expression in the presence and absence of TNF receptors.
- Analyzing p53 and AP-1 interactions and Fas mRNA levels.
- Quantifying Fas protein levels in cardiac tissues of wild-type and TNF receptor-deficient mice.
Main Results:
- ADR-mediated p53 and AP-1 interaction increased Fas mRNA levels independently of TNF receptors.
- Fas protein levels were elevated in cardiac tissues of TNF receptor-deficient mice but not in wild-type mice.
- TNF receptors suppress ADR-induced Fas expression at a post-transcriptional (translational) level.
Conclusions:
- TNF receptors do not affect ADR-induced Fas mRNA transcription.
- TNF receptors play a crucial role in suppressing ADR-induced Fas protein accumulation, likely via translational regulation.
- Understanding this mechanism could lead to novel cardioprotective strategies against chemotherapy-induced cardiotoxicity.
Related Concept Videos
TGF - β Signaling Pathway
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Intracellular Signaling Affects Focal Adhesions
Some...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
